Phosphodiesterase Inhibitor-Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 Palliation

Overview

cited authors

Mills, Kimberly I.; Kaza, Aditya K.; Walsh, Brian K.; Bond, Hilary C.; Ford, Mackenzie; Wypij, David; Thiagarajan, Ravi R.; Almodovar, Melvin C.; Quinonez, Luis G.; Baird, Christopher W.; Emani, Sitaram E.; Pigula, Frank A.; DiNardo, James A.; Kheir, John N.

authors

Pigula, Frank, MD

Publication Date

November 1, 2016

webpage

Web of Science

published in

JOURNAL OF THE AMERICAN HEART ASSOCIATION Journal

Research

keywords

hypoplastic left heart syndrome
hypoxia
oxygen
oxygen consumption
phosphodiesterase inhibitor

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.